Skip to Main Content

++

Clinical Summary

++

Retinal hemorrhages are common above 5200 m (17,060 ft) and are not always associated with acute mountain sickness (AMS). High-altitude retinal hemorrhages (HARH) are rarely symptomatic, but if found over the macula, these hemorrhages may cause temporary blindness. The diagnosis can be established by ophthalmoscopy. Without visualization of the lesion, the differential diagnosis of unilaterally decreased vision or blindness at high altitude includes migraine equivalent, cerebrovascular accident, and dry eye (often unilateral, due to strong winds), as well as all conditions found at sea level.

++

Emergency Department Treatment and Disposition

++

HARH generally resolve spontaneously after descent to lower altitudes. No treatment is necessary for asymptomatic HARH. Patients with HARH associated with a decrease in vision should be referred to an ophthalmologist for follow-up.

++
Figure 16.1.
Graphic Jump Location

High-Altitude Retinal Hemorrhage. Fundoscopic appearance of high-altitude retinal hemorrhage. (Photo contributor: Peter Hackett, MD.)

++

Pearls

++

  1. Patients with blurred vision and unilateral mydriasis at the high altitude should be asked about use of medications, including transdermal scopolamine patches.

  2. As with almost all altitude-related problems, descent is the primary treatment. This is not emergent unless associated with severe altitude illness or progressive visual loss.

  3. Although most symptomatic HARH resolve completely in 2 to 8 weeks, cases of permanent paracentral scotomata have been reported.

++

The authors acknowledge the special contributions of Peter Hackett, MD, The Institute for Altitude Medicine Telluride, Colorado; Edward Otten, MD, University of Cincinnati, Cincinnati, Ohio; James O'Malley, MD, Providence Alaska Medical Center, Anchorage, Alaska; Murray Hamlett, DVM and Kathy McCue, MD, Alaska Native Medical Center, Anchorage, Alaska; Sheryl Olson, RN, Monitou Springs, CO; Luanne Freer, MD, Yellowstone National Park, The Nashville Zoo, Nashville, TN; and the Nova Scotia Museum of Natural History, Halifax, Nova Scotia, Canada. The authors thank Joseph C. Schmidt, MD, Lawrence B. Stack, MD, and Alan B. Storrow, MD for their contributions to prior editions.

++

Clinical Summary

++

High-altitude pulmonary edema (HAPE) is a form of noncardiogenic pulmonary edema, generally beginning within the first 2 to 4 days after ascent above 2500 m (8202 ft). The earliest symptoms are fatigue, weakness, dyspnea on exertion, and decreased exercise performance. Symptoms of acute mountain sickness (AMS) such as headache, anorexia, and lassitude may also be present, but HAPE may develop without AMS. If untreated, a persistent dry cough develops, followed by tachycardia and tachypnea at rest with cyanosis. Patients suffering from HAPE generally experience nocturnal onset, and frequently report progressively worsening symptoms at night. Eventually the victim develops dyspnea at rest and orthopnea with audible crackles in the chest. Pink frothy sputum is a grave sign. Patients may experience concurrent mental status changes and ataxia due to hypoxemia or associated high-altitude cerebral edema (HACE).

++

Emergency Department Treatment and Disposition

++...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessEmergency Medicine Full Site: One-Year Subscription

Connect to the full suite of AccessEmergency Medicine content and resources including advanced 8th edition chapters of Tintinalli’s, high-quality procedural videos and images, interactive board review, an integrated drug database, and more.

$595 USD
Buy Now

Pay Per View: Timed Access to all of AccessEmergency Medicine

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.